Home › Asset managers › Compare 2025-2026 › American Century vs ProShares
American Century 2025-2026 · ProShares 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,123 | 24,929 | 1,050 | 144 | 96.0% | 95.7% |
| Board proposals | 23,824 | 22,789 | 917 | 118 | 96.1% | 95.9% |
| E&S shareholder proposals | 175 | 156 | 19 | 0 | 89.1% | 89.1% |
| Other items | 2,124 | 1,984 | 114 | 26 | 94.6% | 94.1% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
1,194 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | ProShares |
|---|---|---|---|---|---|---|
| NKARTA, INC. | June 10, 2026 | Advisory approval of the compensation paid to the company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| NORTHFIELD BANCORP, INC. | June 25, 2026 | The approval, on an advisory (non-binding) basis, of the compensation that may become payable to the named executive officers of Northfield Bancorp, Inc. in connection with the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| NORTHRIM BANCORP, INC. | May 28, 2026 | APPROVAL OF THE FIRST AMENDMENT TO THE 2025 STOCK INCENTIVE PLAN TO ADD NON-EMPLOYEE DIRECTORS TO THE CLASS OF ELIGIBLE PARTICIPANTS. To approve the First Amendment to the 2025 Stock Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| NORWEGIAN CRUISE LINE HOLDINGS LTD. | June 11, 2026 | Approval of an amendment to our 2013 Performance Incentive Plan (our "Plan"), including an increase in the number of shares available for grant under our Plan Compensation |
Board | For | AGAINST 8 funds |
FOR 21 funds |
| NOVAGOLD RESOURCES INC | May 14, 2026 | Approval of the Amendment to the Company's Stock Award Plan and the Unallocated Entitlements Thereunder - To consider and, if thought advisable, pass, with or without amendment, an ordinary resolution, approving the amendment to the Company's Stock Award Plan to reduce the maximum share reservation limit from 8% to 7% and unallocated awards, rights or other entitlements thereunder. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| NOVOCURE LIMITED | June 3, 2026 | A non-binding advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 10 funds |
| NRG ENERGY, INC. | April 30, 2026 | To approve the NRG Energy, Inc. 2026 Long-Term Incentive Plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 21 funds |
| NU SKIN ENTERPRISES, INC. | May 28, 2026 | Approval of our Amended and Restated 2024 Omnibus Incentive Plan Compensation |
Board | For | FOR 7 funds |
AGAINST 9 funds |
| NUTANIX, INC. | December 12, 2025 | Approval of the amendment and restatement of our 2016 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| NUTANIX, INC. | December 12, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| NUTEX HEALTH INC. | April 23, 2026 | To vote in an advisory capacity concerning the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| NUVALENT, INC. | June 16, 2026 | To approve, on an advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| NUVATION BIO INC. | May 21, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 11 funds |
| NV5 GLOBAL, INC. | July 31, 2025 | To approve, on a non-binding, advisory basis, the compensation that will or may be paid to NV5's named executive officers in connection with the transactions contemplated by the Merger Agreement; and. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 13 funds |
| NVE CORPORATION | August 7, 2025 | Advisory approval of named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| NioCorp Developments Ltd. | April 6, 2026 | Advisory Vote to Approve Named Executive Officer Compensation To approve, on a nonbinding, advisory basis, the compensation of the Company's named executive officers as described in the Company's Management Information and Proxy Circular in respect of the annual general meeting of shareholders of the Company held on April 6, 2026. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 9 funds |
| NorthWestern Energy Group, Inc. | April 2, 2026 | To vote on an advisory vote on the merger-related compensation arrangements of NorthWestern's named executive officers (the "NorthWestern Merger-Related Compensation Proposal"); and Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 22 funds |
| NovaGold Resources Inc. | May 14, 2026 | Approval of All Unallocated Awards under the Performance Share Unit Plan To consider and, if thought advisable, pass, with or without amendment, an ordinary resolution, approving unallocated awards, rights or other entitlements under the Company's Performance Share Unit Plan. Compensation |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| Nurix Therapeutics, Inc. | May 15, 2026 | To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| OCTAVE SPECIALTY GROUP, INC. | May 28, 2026 | To approve, on a non-binding advisory basis, the compensation for our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| OLD NATIONAL BANCORP | May 13, 2026 | Approval of the Company's 2026 Equity Compensation Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 18 funds |
| OLEMA PHARMACEUTICALS, INC. | June 17, 2026 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| OLIN CORPORATION | April 30, 2026 | Approval of Olin Corporation 2026 Long Term Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| OLO INC. | September 9, 2025 | Approval of, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Olo's named executive officers in connection with the Merger. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| OMEROS CORPORATION | June 18, 2026 | Approval of advisory resolution on executive compensation. Say-on-Pay |
Board | For | AGAINST 1 fund |
FOR 12 funds |
| OMNICELL, INC. | May 19, 2026 | Proposal to approve an amendment to the Omnicell, Inc. 2009 Equity Incentive Plan, as amended, to, among other items, add an additional 1,600,000 shares to the number of shares of common stock authorized for issuance under such plan. Compensation |
Board | For | AGAINST 7 funds |
FOR 12 funds |
| OMNICOM GROUP INC. | January 28, 2026 | Approval of the Omnicom 2026 Incentive Award Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 19 funds |
| OMNICOM GROUP INC. | May 5, 2026 | Advisory resolution to approve executive compensation. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 19 funds |
| ONESPAN INC. | June 5, 2026 | To approve an amendment of the Company's Amended and Restated 2019 Omnibus Incentive Plan to increase available shares thereunder by 2,000,000 shares; and Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ONESPAWORLD HOLDINGS LIMITED | June 3, 2026 | Approval of the OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan. Compensation |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| ONEWATER MARINE INC. | February 19, 2026 | Approval of, on an advisory (non-binding) basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| ORASURE TECHNOLOGIES, INC. | June 3, 2026 | To approve an amendment and restatement of the Company's Stock Award Plan to increase the number of shares of Common Stock authorized to be granted under the Plan by 5,000,000 shares and extend its term by an additional ten years. Compensation |
Board | For | AGAINST 5 funds |
FOR 9 funds |
| ORASURE TECHNOLOGIES, INC. | June 3, 2026 | To approve, by an advisory (non-binding) vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ORGANOGENESIS HOLDINGS INC | June 15, 2026 | Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2026 annual meeting of shareholders. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ORIC PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| ORION GROUP HOLDINGS, INC. | May 19, 2026 | The approval of a proposed amendment to the Company's 2022 Long Term Incentive Plan, as amended, to: (i) increase the number of shares of common stock authorized for issuance under the plan by 2,000,000 shares from 3,735,000 shares to 5,735,000 shares; and (ii) expand the per person award limitations thereunder to apply to all Eligible Persons, including all members of the Board. Compensation |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| ORTHOFIX MEDICAL INC. | June 10, 2026 | Advisory and Non-Binding Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| ORUKA THERAPEUTICS, INC. | June 2, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 6 funds |
| OSCAR HEALTH, INC. | June 4, 2026 | Advisory vote to approve named executive officer compensation ("Say-on-Pay"). Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 9 funds |
| OTIS WORLDWIDE CORPORATION | May 27, 2026 | Advisory Vote to Approve Executive Compensation Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 19 funds |
| OUTFRONT MEDIA INC. | June 3, 2026 | Approval of the OUTFRONT Media Inc. Amended and Restated Omnibus Stock Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| OXFORD INDUSTRIES, INC. | June 23, 2026 | Approve the Oxford Industries, Inc. Long-Term Stock Incentive Plan, as amended and restated, to, among other things, authorize 750,000 additional shares of common stock for issuance under the plan Compensation |
Board | For | AGAINST 6 funds |
FOR 12 funds |
| PACS GROUP, INC. | June 10, 2026 | To approve, on an advisory (non binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 5 funds |
| PAGERDUTY, INC. | June 18, 2026 | To conduct an advisory, non-binding vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| PALO ALTO NETWORKS, INC. | December 9, 2025 | To approve an amendment to the Palo Alto Networks, Inc. 2021 Equity Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 28 funds |
| PALOMAR HOLDINGS, INC. | May 21, 2026 | Advisory Vote to Approve Named Executive Officer Compensation ("Say-On-Pay-Vote"). Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 12 funds |
| PAPA JOHN'S INTERNATIONAL, INC. | April 30, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 14 funds |
| PARK AEROSPACE CORP. | July 22, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| PARK NATIONAL CORPORATION | April 27, 2026 | Approval of the Park National Corporation 2026 Long-Term Incentive Plan for Non-Employee Directors. Compensation |
Board | For | AGAINST 5 funds |
FOR 16 funds |
| PAYCHEX, INC. | October 9, 2025 | ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 28 funds |
| PAYONEER GLOBAL INC. | June 9, 2026 | Non-binding advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 14 funds |
| PAYPAL HOLDINGS, INC. | May 19, 2026 | Approval of the PayPal Holdings, Inc. 2026 Equity Incentive Award Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 28 funds |
| PC Connection, Inc. | May 13, 2026 | To elect six directors to serve until the 2027 Annual Meeting of Stockholders: Patricia Gallup Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 12 funds |
| PDF SOLUTIONS, INC. | June 16, 2026 | To approve our Eleventh Amended and Restated 2011 Stock Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 12 funds |
| PEDIATRIX MEDICAL GROUP, INC. | May 7, 2026 | Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan Compensation |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| PEGASYSTEMS INC. | June 16, 2026 | To approve, by a non-binding advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 20 funds |
FOR 7 funds |
| PENN ENTERTAINMENT, INC. | June 16, 2026 | Approval of the third amendment to our 2022 Long-Term Incentive Compensation Plan. Compensation |
Board | For | FOR 3 funds |
AGAINST 3 funds |
| PENN ENTERTAINMENT, INC. | June 16, 2026 | Approval, on an advisory basis, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| PENNYMAC FINANCIAL SERVICES, INC. | June 3, 2026 | To approve, by non-binding vote, our executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 11 funds |
| PENUMBRA, INC. | May 6, 2026 | To approve, on a non-binding, advisory basis, the compensation that Penumbra's named executive officers will or may be eligible to receive in connection with the Merger; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 7 funds |
| PEOPLES FINANCIAL SERVICES CORP. | May 22, 2026 | To Amend the Peoples Financial Services Corp. 2023 Equity Incentive Plan to Increase the Number of Shares that may be issued under the Plan to 300,000 Shares. Compensation |
Board | For | AGAINST 6 funds |
FOR 9 funds |
| PERMA-FIX ENVIRONMENTAL SERVICES, INC. | July 24, 2025 | Approve, by non-binding vote, the 2024 compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| PERSONALIS, INC. | May 12, 2026 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 10 funds |
| PFIZER INC. | April 23, 2026 | 2026 advisory approval of executive compensation Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 20 funds |
| PG&E CORPORATION | May 21, 2026 | Advisory Vote to Approve Executive Compensation Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 20 funds |
| PHATHOM PHARMACEUTICALS, INC. | May 19, 2026 | To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). Compensation |
Board | For | AGAINST 2 funds |
FOR 12 funds |
| PHIBRO ANIMAL HEALTH CORPORATION | November 4, 2025 | Approval, on an advisory basis, of the compensation paid to the named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 15 funds |
| PHREESIA, INC. | June 24, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| PIEDMONT LITHIUM INC. | August 22, 2025 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Piedmont to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 8 funds |
| PINTEREST, INC. | May 21, 2026 | Approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 11 funds |
| PITNEY BOWES INC. | May 12, 2026 | Non-binding Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 14 funds |
| PJT PARTNERS INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Proposal 2). Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 12 funds |
| PLAINS GP HOLDINGS, L.P. | May 20, 2026 | The approval, on a non-binding advisory basis, of our 2025 named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| PLANET LABS PBC | July 10, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 8 funds |
| PLAYTIKA HOLDING CORP. | June 11, 2026 | Advisory Vote to Approve the Compensation of Our Named Executive Officers ("Say-on-Pay" Proposal). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| PLEXUS CORP. | February 18, 2026 | Advisory vote to approve the compensation of Plexus Corp.'s named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement; Say-on-Pay |
Board | For | AGAINST 14 funds |
FOR 14 funds |
| POLARIS INC. | April 30, 2026 | Adoption of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan Compensation |
Board | For | AGAINST 9 funds |
FOR 18 funds |
| POLARIS INC. | April 30, 2026 | Advisory vote to approve the compensation of the Company's Named Executive Officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 18 funds |
| PORCH GROUP, INC. | June 10, 2026 | To approve of, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| PORTILLO'S INC. | June 9, 2026 | Advisory Vote on Executive Compensation Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| POST HOLDINGS, INC. | January 29, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| PPG INDUSTRIES, INC. | April 16, 2026 | Approve the PPG Industries, Inc. 2026 Omnibus Incentive Plan Compensation |
Board | For | AGAINST 13 funds |
FOR 21 funds |
| PPL CORPORATION | May 13, 2026 | Approval of the PPL Corporation Second Amended and Restated 2012 Stock Incentive Plan Compensation |
Board | For | AGAINST 10 funds |
FOR 18 funds |
| PRA GROUP, INC. | June 16, 2026 | Approval of an amendment to increase the share authorization under PRA Group, Inc.'s 2022 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 12 funds |
| PRAXIS PRECISION MEDICINES, INC. | June 10, 2026 | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. Say-on-Pay |
Board | For | AGAINST 11 funds |
FOR 6 funds |
| PREMIER, INC. | November 21, 2025 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation proposal"). Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 13 funds |
| PRESTIGE CONSUMER HEALTHCARE INC. | August 5, 2025 | Say on Pay - An advisory vote on the resolution to approve the compensation of Prestige Consumer Healthcare Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 15 funds |
| PRIVIA HEALTH GROUP, INC. | May 20, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers ("NEOs"). Compensation |
Board | For | AGAINST 3 funds |
FOR 12 funds |
| PRO-DEX, INC. | November 20, 2025 | Advisory vote to approve the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
| PROG HOLDINGS, INC. | May 6, 2026 | Approval of the amendment to the PROG Holdings, Inc. Amended and Restated 2015 Equity and Incentive Plan. Compensation |
Board | For | AGAINST 9 funds |
FOR 12 funds |
| PROGRESS SOFTWARE CORPORATION | May 7, 2026 | To approve, on an advisory basis, the compensation of Progress Software Corporation's named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 14 funds |
| PROGYNY, INC. | May 21, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the company's named executive officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 12 funds |
| PROLOGIS, INC. | April 28, 2026 | Advisory Vote to Approve the Company's Executive Compensation for 2025. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 18 funds |
| PROTARA THERAPEUTICS, INC. | June 12, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 9 funds |
| PROTHENA CORPORATION PLC | May 14, 2026 | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| PTC THERAPEUTICS, INC. | June 2, 2026 | Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 15 funds |
| PUBMATIC, INC. | May 29, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 9 funds |
| PUMA BIOTECHNOLOGY, INC. | June 11, 2026 | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 10 funds |
| PURE CYCLE CORPORATION | January 14, 2026 | Approval on an advisory basis, of compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| PURECYCLE TECHNOLOGIES, INC. | May 7, 2026 | APPROVE, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 9 funds |
← Previous Page 8 of 12 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.